Skip to main content
Skip to section navigation
Skip to footer
About
Discover Mineralys
Purpose & Values
Our Team
Science
Lorundrostat
Aldosterone
Hypertension
Cardio-Renal-Metabolic Syndrome
Pipeline
Investors
Publications
Contact Us
Careers & Culture
Partnering
Contact Form
Menu
About
Discover Mineralys
Purpose & Values
Our Team
Science
Lorundrostat
Aldosterone
Hypertension
Cardio-Renal-Metabolic Syndrome
Pipeline
Investors
Publications
Contact Us
Careers & Culture
Partnering
Contact Form
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
SEC Filings
All SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Filing Type:
View All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
Date
Form
Description
PDF
XBRL
Pages
02/07/23
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
02/07/23
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
02/06/23
8-A12B
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
3
02/02/23
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-FILING FEES
EX-1.1
EX-3.1
EX-3.3
EX-4.1
EX-4.2
EX-5.1
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-23.1
459
01/18/23
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-FILING FEES
EX-3.1
EX-3.2
EX-3.3
EX-3.4
EX-4.2
EX-10.1
EX-10.2
EX-10.3
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-23.1
505
12/29/22
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
216
12/07/22
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
214
11/04/22
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
expand_more
EX-3.1
EX-3.2
EX-4.2
EX-10.1
EX-10.5
EX-10.6
EX-10.7
EX-10.9
375
06/13/22
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
…
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Email Alerts
Contacts
RSS News Feed